Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro

Journal of Nutritional Biochemistry

Volumn 23, Issue 1, 2012, Pages 39-50

  Youssef Elabd, Elham M ^a   McGee, Kirsty C ^b   Tripathi, Gyanendra ^b   Aldaghri, Nasser ^f   Abdalla, Mohga S ^c   Sharada, Hayat M ^c   Ashour, Esmat ^a   Amin, Ashraf I ^d   Ceriello, Antonio ^e   O'Hare, Joseph P ^b   Kumar, Sudhesh ^b   McTernan, Philip G ^b   Harte, Alison L ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Helwan University   (Egypt)

^d National Institute of Diabetes and Endocrinology   (Egypt)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Glucose; Human adipose tissue; Inflammation; Obesity; Saturated fatty acids; Toll like receptors

Indexed keywords

GLUCOSE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 9; MYELOID DIFFERENTIATION FACTOR 88; SATURATED FATTY ACID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ABDOMINAL FAT; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; FATTY ACIDS; FEMALE; GLUCOSE; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-6; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TOXICITY TESTS, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83355164502     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.11.003     Document Type: Article

References (43)

1. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 14(444(7121)):860-867.
2. Schaeffler A., Gross P., Buettner R., Bollheimer C., Buechler C., Neumeier M., et al. Fatty acid-induction of Toll-like receptor-4/nuclear factor-B pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009, 126(2):233-245.
3. Wolowczuk I., Verwaerde C., Viltart O., Delanoye A., Delacre M., Pot B., et al. Feeding our immune system: impact on metabolism. Clin Dev Immunol 2008, 639803:2008.
4. Ceolotto G., Gallo A., Miola M., Sartori M., Trevisan R., Del Prato S., et al. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 1999, 48(6):1316-1322.
5. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. J Cardiol 2007, 99(4A):15B-26B.
6. Jain S.K., Kannan K., Lim G., Matthews-Greer J., McVie R., Bocchini J.A. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 2003, 26(7):2139-2143.
7. Jialal I., Devaraj S., Venugopal S.K. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res 2002, 36(12):1331-1336.
8. Shanmugam N., Reddy M.A., Guha M., Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003, 52(5):1256-1264.
9. Kim F., Pham M., Luttrell I., Bannerman D.D., Tupper J., Thaler J., et al. Toll-Like Receptor-4 mediates vascular inflammation and insulin resistance in diet induced obesity. Circ Res 2007, 100(11):1589-1596.
10. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001, 276(20):16683-16689.
11. Lee J.Y., Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 2006, 21(2):174-185.
12. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15(8):914-920.
13. Festa A., D'Agostino R., Tracy R.P., Haffner S.M. Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of Type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 4:1131-1137.
14. Hu F.B., Meigs J.B., Li T.Y., Rifai N., Manson J.E. Inflammatory markers and risk of developing Type 2 diabetes in women. Diabetes 2004, 53(3):693-700.
15. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of Inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999, 15(353(9165)):1649-1652.
16. Spranger J., Kroke A., Möhlig M., Hoffmann K., Bergmann M.M., Ristow M., et al. Inflammatory cytokines and the risk to develop Type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52(3):812-817.
17. Frank R.N. Metabolic memory in diabetes is true long-term memory. Arch Ophthalmol 2009, 127(3):330-331.
18. Ihnat M.A., Thorpe J.E., Ceriello A. Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diab Med 2007, 24(6):582-586.
19. LeRoith D., Fonseca V., Vinik A. Metabolic memory in diabetes - focus on insulin. Diabetes Metab Res Rev 2005, 21(2):85-90.
20. O'Keefe J.H., Bell D.S. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007, 100(5):899-904.
21. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 1990, 263:2893-2898.
22. Kim H.S., Han M.S., Chung K.W., Kim S., Kim E., Kim M.J., et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007, 27(2):321-333.
23. Creely S.J., McTernan P.G., Kusminski C.M., Fisher M., Da Silva N.F., Khanolkar M., et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and Type 2 diabetes. Am J Physiol Endocrinol Metab 2007, 292(3):E740-E747.
24. Kos K., Baker A.R., Jernas M., Harte A.L., Clapham J.C., O'Hare J.P., et al. DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue. Diabetes Obes Metab 2009, 11(4):285-292.
25. Kos K., Harte A.L., O'Hare P.J., Kumar S., McTernan P.G. Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT). Clin Endocrinol (Oxf) 2009, 70(3):383-389.
26. McTernan P.G., Anwar A., Eggo M.C., Barnett A.H., Stewart P.M., Kumar S. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. Int J Obes Relat Metab Disord 2000, 24(7):875-881.
27. McTernan P.G., Harte A.L., Anderson L.A., Green A., Smith S.A., Holder J.C., et al. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes 2002, 51(5):1493-1498.
28. McTernan P.G., McTernan C.L., Chetty R., Jenner K., Fisher F.M., Lauer M.N., et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002, 87(5):2407.
29. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57(11):3090-3098.
30. Fan J., Frey R.S., Malik A.B. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003, 112(8):1234-1243.
31. Saillan-Barreau C., Cousin B., André M., Villena P., Casteilla L., Pénicaud L. Human adipose cells as candidates in defense and tissue remodeling phenomena. Biochem Biophys Res Commun 2003, 309(3):502-505.
32. Yang X., Murthy V., Schultz K., Tatro J.B., Fitzgerald K.A., Beasley D. Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2006, 291(5):H2334-H2343.
33. Björkbacka H., Fitzgerald K.A., Huet F., Li X., Gregory J.A., Lee M.A., et al. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol Genomics 2004, 19(3):319-330.
34. Kelley D.S., Siegel D., Fedor D.M., Adkins Y., Mackey B.E. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009, 139(3):495-501.
35. Hayden R.E., Davies N.J., Khanim F.L., Birtwistle J., Delgado J., Pearce C., et al. Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta(12,14,)PGJ(2). Leukemia 2009, 23(2):292-304.
36. Kawai T., Takeuchi O., Fujita T., Inoue J., Mühlradt P.F., Sato S., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001, 167(10):5887-5894.
37. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11(1):115-122.
38. Baker A.R., Harte A.L., Howell N., Pritlove D.C., Ranasinghe A.M., da Silva N.F., Youssef E.M., Khunti K., Davies M.J., Bonser R.S., et al. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 2008, 94(1):261-267.
39. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009, 15(8):930-939.
40. Shoelson S.E., Goldfine A.B. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med 2009, 15(4):373-374.
41. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, (8):921-929.
42. Hall W.L. Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function. Nutr Res Rev 2009, 22(1):18-38.
43. Sharma A.M., Chetty V.T. Obesity, hypertension and insulin resistance. Acta Diabetol 2005, 42(Suppl 1):S.